Track the 동구바이오제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 동구바이오제약 has recorded 58 reports. Market capitalisation: €104.9bn. The latest transaction was reported on 15 July 2026 (Sale). Among the most active insiders: 조용준. The full history is accessible without an account.
56
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
17 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,288 of 28,932 companies
70.2
score / 100
Value
68
Quality
72
FCF yld-26%
Earn yld52%
EV/EBITDA3.1x
ROE·
Gross mgn60%
Net mgn21%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Donggu Bio Pharmaceutical is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.